CASSIDY & ASSOCIATES, INC.

Lobbying for SEQIRUS USA INC · Pharmaceutical Manufacturing

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Oct 15, 2025

Lobbying activity 3

Budget/Appropriations

FY26 Appropriations

Defense

FY26 National Defense Authorization Act

Veterans

FY25 & FY26 National Defense Authorization and FY25 & FY26 Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.